The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2022

Filed:

Sep. 17, 2019
Applicant:

2seventy Bio, Inc., Cambridge, MA (US);

Inventors:

Jordan Jarjour, Seattle, WA (US);

Alexander Astrakhan, Seattle, WA (US);

Michael Certo, Medford, MA (US);

Assignee:

2seventy bio, Inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); C07K 14/705 (2006.01); C07K 14/725 (2006.01); C07K 14/73 (2006.01); C07K 14/735 (2006.01); C12N 9/06 (2006.01); C12N 9/16 (2006.01); A61K 35/17 (2015.01); A61K 45/06 (2006.01); C07K 16/40 (2006.01); C12N 9/12 (2006.01); C12N 9/90 (2006.01); C12N 15/85 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 35/17 (2013.01); A61K 39/0005 (2013.01); A61K 45/06 (2013.01); C07K 14/7051 (2013.01); C07K 14/7056 (2013.01); C07K 14/70503 (2013.01); C07K 14/70514 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 14/70535 (2013.01); C07K 14/70578 (2013.01); C07K 14/70596 (2013.01); C07K 16/2896 (2013.01); C07K 16/40 (2013.01); C12N 9/003 (2013.01); C12N 9/12 (2013.01); C12N 9/16 (2013.01); C12N 9/90 (2013.01); C12N 15/85 (2013.01); C12Y 207/11001 (2013.01); C12Y 502/01008 (2013.01); C07H 21/04 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); C07K 2319/03 (2013.01); C07K 2319/70 (2013.01); C12N 2510/00 (2013.01);
Abstract

The present disclosure relates to compositions and methods for using cells having chemically-induced fusion protein complexes to spatially and temporally control immune cell signal initiation and downstream responses for treating disease. As a preferred example, the present disclosure relates to fusion polypeptides comprising (a) a first polypeptide comprising a first secretion signal, a first multimerization domain, a first transmembrane domain, and an actuator domain, (b) a viral self-cleaving polypeptide, and (c) a second polypeptide comprising a second secretion signal, a binding domain that comprises a single chain antibody, a receptor ectodomain, or a ligand, a second multimerization domain, and a second transmembrane domain.


Find Patent Forward Citations

Loading…